Cargando…

Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Morales-Kastresana, Aizea, Miguel, Sanmamed F, Rodriguez, Inmaculada, Palazon, Asis, Martinez-Forero, Ivan, Labiano, Sara, Hervas-Stubbs, Sandra, Sangro, Bruno, Ochoa, Carmen, Rouzaut, Ana, Azpilikueta, Arantza, Bolaños, Elixabet, Jure-Kunkel, Maria, Gutgemann, Ines, Melero, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990327/
http://dx.doi.org/10.1186/2051-1426-1-S1-O7
_version_ 1782312261010849792
author Morales-Kastresana, Aizea
Miguel, Sanmamed F
Rodriguez, Inmaculada
Palazon, Asis
Martinez-Forero, Ivan
Labiano, Sara
Hervas-Stubbs, Sandra
Sangro, Bruno
Ochoa, Carmen
Rouzaut, Ana
Azpilikueta, Arantza
Bolaños, Elixabet
Jure-Kunkel, Maria
Gutgemann, Ines
Melero, Ignacio
author_facet Morales-Kastresana, Aizea
Miguel, Sanmamed F
Rodriguez, Inmaculada
Palazon, Asis
Martinez-Forero, Ivan
Labiano, Sara
Hervas-Stubbs, Sandra
Sangro, Bruno
Ochoa, Carmen
Rouzaut, Ana
Azpilikueta, Arantza
Bolaños, Elixabet
Jure-Kunkel, Maria
Gutgemann, Ines
Melero, Ignacio
author_sort Morales-Kastresana, Aizea
collection PubMed
description
format Online
Article
Text
id pubmed-3990327
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39903272014-05-01 Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma Morales-Kastresana, Aizea Miguel, Sanmamed F Rodriguez, Inmaculada Palazon, Asis Martinez-Forero, Ivan Labiano, Sara Hervas-Stubbs, Sandra Sangro, Bruno Ochoa, Carmen Rouzaut, Ana Azpilikueta, Arantza Bolaños, Elixabet Jure-Kunkel, Maria Gutgemann, Ines Melero, Ignacio J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990327/ http://dx.doi.org/10.1186/2051-1426-1-S1-O7 Text en Copyright © 2013 Morales-Kastresana et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Morales-Kastresana, Aizea
Miguel, Sanmamed F
Rodriguez, Inmaculada
Palazon, Asis
Martinez-Forero, Ivan
Labiano, Sara
Hervas-Stubbs, Sandra
Sangro, Bruno
Ochoa, Carmen
Rouzaut, Ana
Azpilikueta, Arantza
Bolaños, Elixabet
Jure-Kunkel, Maria
Gutgemann, Ines
Melero, Ignacio
Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
title Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
title_full Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
title_fullStr Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
title_full_unstemmed Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
title_short Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
title_sort therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-b7-h1, cd137 and ox40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990327/
http://dx.doi.org/10.1186/2051-1426-1-S1-O7
work_keys_str_mv AT moraleskastresanaaizea therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT miguelsanmamedf therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT rodriguezinmaculada therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT palazonasis therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT martinezforeroivan therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT labianosara therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT hervasstubbssandra therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT sangrobruno therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT ochoacarmen therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT rouzautana therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT azpilikuetaarantza therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT bolanoselixabet therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT jurekunkelmaria therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT gutgemannines therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma
AT meleroignacio therapeuticactivityofacombinationofimmunostimulatorymonoclonalantibodiesantib7h1cd137andox40onacmycdrivenspontaneoustransgenicmodelofhepatocellularcarcinoma